Meijers-Heijboer EJ - Search Results

1

[Initial Dutch results with a presymptomatic DNA tests in familial breast/ovarian carcinoma. Rotterdamse Werkgroep voor Erfelijke Tumoren].

Klijn JG, Devilee P, van Geel AN, Tilanus-Linthorst MM, Dudok-de Wit C, Meijers-Heijboer EJ. Klijn JG, et al. Ned Tijdschr Geneeskd. 1995 Mar 4;139(9):439-45. Ned Tijdschr Geneeskd. 1995. PMID: 7891765 Dutch.

2

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Verhoog LC, Brekelmans CT, Seynaeve C, Dahmen G, van Geel AN, Bartels CC, Tilanus-Linthorst MM, Wagner A, Devilee P, Halley DJ, van den Ouweland AM, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. J Clin Oncol. 1999 Nov;17(11):3396-402. doi: 10.1200/JCO.1999.17.11.3396. J Clin Oncol. 1999. PMID: 10550133

3

Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM, Meijers-Heijboer EJ, Crepin CM, van Geel AA, Menke M, Verhoog LC, van den Ouweland A, Obdeijn IM, Klijn JG; Rotterdam Committee for Medical and Genetic Counseling. Brekelmans CT, et al. J Clin Oncol. 2001 Feb 15;19(4):924-30. doi: 10.1200/JCO.2001.19.4.924. J Clin Oncol. 2001. PMID: 11181654

4

[Preventive surgical prcedures for inherited risk of breast cancer].

Menke-Pluymers MB, Seynaeve C, van Geel AN, Klijn JG, Meijers-Heijboer EJ, Eggermont AM. Menke-Pluymers MB, et al. Among authors: meijers heijboer ej. Ned Tijdschr Geneeskd. 2005 Nov 26;149(48):2663-7. Ned Tijdschr Geneeskd. 2005. PMID: 16358615 Review. Dutch.

5

BRCA1 in the family: a case description of the psychological implications.

DudokdeWit AC, Tibben A, Frets PG, Meijers-Heijboer EJ, Devilee P, Klijn JG, Oosterwijk JC, Niermeijer MF. DudokdeWit AC, et al. Am J Med Genet. 1997 Jul 11;71(1):63-71. doi: 10.1002/(sici)1096-8628(19970711)71:1<63::aid-ajmg12>3.0.co;2-t. Am J Med Genet. 1997. PMID: 9215771

6

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, Tilanus-Linthorst MM, Bartels CC, Wagner A, van den Ouweland A, Devilee P, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Lancet. 1998 Jan 31;351(9099):316-21. doi: 10.1016/s0140-6736(97)07065-7. Lancet. 1998. PMID: 9652611

7

Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.

Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Duivenvoorden HJ, Tibben A, Wagner A, van der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF. Lodder LN, et al. J Med Genet. 1999 Dec;36(12):906-13. J Med Genet. 1999. PMID: 10593998 Free PMC article.

8

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT, Seynaeve C, Tilanus-Linthorst MM, Wagner A, Dukel L, Devilee P, van den Ouweland AM, van Geel AN, Klijn JG. Meijers-Heijboer EJ, et al. Lancet. 2000 Jun 10;355(9220):2015-20. doi: 10.1016/s0140-6736(00)02347-3. Lancet. 2000. PMID: 10885351

9

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer.

Verhoog LC, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. Br J Cancer. 2000 Aug;83(3):384-6. doi: 10.1054/bjoc.2000.1239. Br J Cancer. 2000. PMID: 10917555 Free PMC article.

10

Prognostic significance of germline BRCA2 mutations in hereditary breast cancer patients.

Verhoog LC, Berns EM, Brekelmans CT, Seynaeve C, Meijers-Heijboer EJ, Klijn JG. Verhoog LC, et al. J Clin Oncol. 2000 Nov 1;18(21 Suppl):119S-24S. J Clin Oncol. 2000. PMID: 11060339 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page